K. S. Abelson, M. Kommalage, and A. U. Höglund, Spinal cholinergic involvement after treatment with aspirin and paracetamol in rats, Neurosci. Lett, vol.368, pp.116-120, 2004.

, Can. Pain Soc. J. Société Can. Pour Trait. Douleur, vol.18, pp.63-67

D. A. Barrière, C. Mallet, A. Blomgren, C. Simonsen, L. Daulhac et al., Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain, PLoS ONE, vol.8, p.70690, 2013.

D. A. Barrière, C. Mallet, A. Blomgren, C. Simonsen, L. Daulhac et al., Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain, PloS One, vol.8, p.70690, 2013.

D. L. Bars, M. Gozariu, and S. W. Cadden, , 2001.

, Animal Models of Nociception, Pharmacol. Rev, vol.53, pp.597-652

M. Barton, E. Eberle, S. , and H. , The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil, Eur. J. Pharmacol. European journal of pharmacology, pp.79-85, 2005.

T. Bartsch, Y. E. Knight, and P. J. Goadsby, Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception, Ann. Neurol, vol.56, pp.371-381, 2004.

A. I. Basbaum and H. L. Fields, Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry, Annu. Rev. Neurosci, vol.7, pp.309-338, 1984.

D. N. Bateman, Limiting paracetamol pack size: has it worked in the UK?, Clin. Toxicol. Phila. Pa, vol.47, pp.536-541, 2009.

D. N. Bateman, Pack size and paracetamol overdose: 16 years later, Clin. Toxicol. Phila. Pa, vol.52, pp.821-823, 2014.

L. Becerra, H. C. Breiter, R. Wise, R. G. Gonzalez, and D. Borsook, Reward circuitry activation by noxious thermal stimuli, Neuron, vol.32, pp.927-946, 2001.

L. Becerra, K. Harter, R. G. Gonzalez, and D. Borsook, Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers, Anesth. Analg, vol.103, pp.208-216, 2006.

K. G. Becker and S. T. Schultz, Similarities in features of autism and asthma and a possible link to acetaminophen use, Med. Hypotheses, vol.74, pp.7-11, 2010.

M. M. Behbehani and H. L. Fields, Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia, Brain Res, vol.170, pp.85-93, 1979.

M. M. Behbehani, M. R. Jiang, S. D. Chandler, and M. Ennis, The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat, Pain, vol.40, pp.195-204, 1990.

M. M. Behbehani and A. Pert, A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques, Brain Res, vol.324, pp.35-42, 1984.

M. Beltramo, F. R. Fonseca, . De, M. Navarro, A. Calignano et al., Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor, J. Neurosci. Off. J. Soc. Neurosci, vol.20, pp.3401-3407, 2000.

M. Beltramo, P. , and D. , Carriermediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol, 2000.

, Neuroreport, vol.11, pp.1231-1235, 2000.

M. Beltramo, N. Stella, A. Calignano, S. Y. Lin, A. Makriyannis et al., Functional role of high-affinity anandamide transport, as revealed by selective inhibition, Science, vol.277, pp.1094-1097, 1997.

E. E. Benarroch, Descending monoaminergic pain modulation: bidirectional control and clinical relevance, Neurology, vol.71, pp.217-221, 2008.

O. Berge, K. Hole, and S. Ögren, Attenuation of morphine-induced analgesia by pchlorophenylalanine and p-chloroamphetamine: Test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement, Brain Res, vol.271, pp.51-64, 1983.

M. J. Berridge, P. Lipp, and M. D. Bootman, The versatility and universality of calcium signalling, Nat. Rev. Mol. Cell Biol, vol.1, pp.11-21, 2000.

A. Bertolini, A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi et al., Paracetamol: new vistas of an old drug, CNS Drug Rev, vol.12, pp.250-275, 2006.

L. A. Birder, A. J. Kanai, W. C. Groat, . De, S. Kiss et al., Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells, Proc. Natl. Acad. Sci, vol.98, pp.13396-13401, 2001.

T. Bisogno, M. Maccarrone, L. Petrocellis, J. De, A. Finazzi-agrò et al., The uptake by cells of 2arachidonoylglycerol, an endogenous agonist of cannabinoid receptors: Membrane transporter(s) for endocannabinoids, Eur. J. Biochem, vol.268, pp.1982-1989, 2001.

R. G. Bittar, I. Kar-purkayastha, S. L. Owen, R. E. Bear, A. Green et al., Deep brain stimulation for pain relief: a meta-analysis, J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas, vol.12, pp.515-519, 2005.

R. J. Bodnar, Endogenous opiates and behavior, Peptides, vol.50, pp.55-95, 2012.
DOI : 10.1016/j.peptides.2013.10.001

R. J. Bodnar, A. Kirchgessner, G. Nilaver, J. Mulhern, and E. A. Zimmerman, Intraventricular capsaicin: Alterations in analgesic responsivity without depletion of substance P, Neuroscience, vol.7, pp.631-638, 1982.

J. Bonnefont, A. P. Alloui, E. Chapuy, E. P. Clottes, and A. P. Eschalier, Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin Test: Evidence for a Supraspinal, Serotonin-dependent Antinociceptive Mechanism, 2003.

. Anesthesiol and . Oct, , vol.99, pp.976-981, 2003.

J. Bonnefont, E. Chapuy, E. Clottes, A. Alloui, and A. Eschalier, Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT, Pain, vol.114, pp.482-490, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00077279

J. Bonnefont, J. Courade, A. Alloui, and A. Eschalier, Drugs, vol.63, pp.1-4, 2003.

J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet et al., , 2007.

, Acetaminophen recruits spinal p42/p44 MAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system, Mol. Pharmacol, vol.71, pp.407-415

L. Booker, S. G. Kinsey, R. A. Abdullah, J. L. Blankman, J. Z. Long et al., The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice, Br. J. Pharmacol, vol.165, pp.2485-2496, 2012.

D. Borsook and L. Becerra, CNS animal fMRI in pain and analgesia, Neurosci. Biobehav. Rev, vol.35, pp.1125-1143, 2011.

D. Borsook and L. Becerra, CNS animal fMRI in pain and analgesia, Neurosci Biobehav Rev, vol.35, pp.1125-1168

M. Bortolato, P. Campolongo, R. A. Mangieri, M. L. Scattoni, R. Frau et al., , 2006.

, Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404, Neuropsychopharmacology, vol.31, pp.2652-2659

R. Botting, A. , and S. , COX-3 and the mechanism of action of paracetamol/acetaminophen, Prostaglandins Leukot. Essent. Fatty Acids Prostaglandins, pp.85-92, 2005.

R. M. Botting, Mechanism of action of acetaminophen: is there a cyclooxygenase 3?, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.31, pp.202-210, 2000.

D. Bouhassira, , 2008.

P. Presse-médicale and . Fr, , vol.37, pp.311-314, 1983.

E. Bourinet, A. Alloui, A. Monteil, C. Barrère, B. Couette et al., Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception, EMBO J, vol.24, pp.315-324, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00016908

O. Boutaud, D. M. Aronoff, J. H. Richardson, L. J. Marnett, and J. A. Oates, Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases, Proc. Natl. Acad. Sci, vol.99, pp.7130-7135, 2002.

J. M. Braz and A. I. Basbaum, Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits, J. Comp. Neurol, vol.507, pp.1990-2003, 2008.

E. J. Breda, . Van, B. Worp, . Van-der, M. Gemert et al., , 2002.

. , The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: protocol for a phase II double-blind randomised placebo-controlled trial, BMC Cardiovasc. Disord, vol.2, p.7

C. D. Breder, D. Dewitt, K. , and R. P. , Characterization of inducible cyclooxygenase in rat brain, J. Comp. Neurol, vol.355, pp.296-315, 1995.

B. , B. B. , A. , and J. , The fate of acetanilide in man, J. Pharmacol. Exp. Ther, vol.94, pp.29-38, 1948.

T. G. Brodie, The immediate action of an intravenous injection of blood-serum, J. Physiol, vol.26, pp.48-71, 1900.

M. W. Buczynski and L. H. Parsons, Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls, Br. J. Pharmacol, vol.160, pp.423-442, 2010.

C. Bunchorntavakul and K. R. Reddy, , 2013.

, Acetaminophen-related Hepatotoxicity. Clin. Liver Dis, vol.17, pp.587-607

S. E. Burgess, L. R. Gardell, M. H. Ossipov, T. P. Malan, T. W. Vanderah et al., Timedependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain, J. Neurosci. Off. J. Soc. Neurosci, vol.22, pp.5129-5136, 2002.

A. R. Burkey, E. Carstens, J. J. Wenniger, J. Tang, J. et al., An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception, J Neurosci, vol.16, pp.6612-6635, 1996.

M. Burtscher, H. Gatterer, M. Philippe, P. Krüsmann, S. Kernbeiss et al., Effects of a single low-dose acetaminophen on body temperature and running performance in the heat: a pilot project, Int. J. Physiol. Pathophysiol. Pharmacol, vol.5, pp.190-193, 2013.

A. Busquets-garcia, E. Puighermanal, A. Pastor, R. Torre, . De-la et al., Differential Role of Anandamide and 2Arachidonoylglycerol in Memory and Anxiety-like Responses, Biol. Psychiatry, vol.70, pp.479-486, 2011.

C. ,

G. A. Cabral, E. S. Raborn, L. Griffin, J. Dennis, and F. Marciano-cabral, CB2 receptors in the brain: role in central immune function, Br. J. Pharmacol, vol.153, pp.240-251, 2008.

K. Cahill and M. Ussher, Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation, Cochrane Database Syst. Rev. CD005353, 2007.

A. Cahn and P. Hepp, Das Antifebrin, ein neues Fiebermittel. Cent. Klein Med, vol.7, pp.561-564, 1886.

A. Calignano, G. L. Rana, A. Giuffrida, P. , and D. , Control of pain initiation by endogenous cannabinoids, Nature, vol.394, pp.277-281, 1998.

B. Calvino, Paracétamol : ne pas dépasser la dose prescrite, 2009.

F. A. Campbell, M. R. Tramèr, D. Carroll, D. J. Reynolds, R. A. Moore et al., Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review, BMJ, vol.323, pp.13-16, 2001.

J. D. Carlson, J. J. Maire, M. E. Martenson, and M. M. Heinricher, Sensitization of painmodulating neurons in the rostral ventromedial medulla after peripheral nerve injury, J. Neurosci. Off. J. Soc. Neurosci, vol.27, pp.13222-13231, 2007.

P. C. Casarotto, A. L. Terzian, D. C. Aguiar, H. Zangrossi, F. S. Guimar|-;-|es et al., Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats, Neuropsychopharmacology, vol.37, pp.478-486, 2011.

M. Caterina, Vanilloid receptors take a TRP beyond the sensory afferent, Pain, vol.105, pp.5-9, 2003.

M. J. Caterina, A. Leffler, A. B. Malmberg, W. J. Martin, J. Trafton et al., , 2000.

, Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor, Science, vol.288, pp.306-313

M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine et al., The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature, vol.389, pp.816-824, 1997.

D. J. Cavanaugh, A. T. Chesler, A. C. Jackson, Y. M. Sigal, H. Yamanaka et al., Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells, J. Neurosci. Off. J. Soc. Neurosci, vol.31, pp.5067-5077, 2011.

D. J. Cavanaugh, A. T. Chesler, A. C. Jackson, Y. M. Sigal, H. Yamanaka et al., Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells, J Neurosci, vol.31, pp.5067-77

J. Ceccarini, C. Casteels, M. Koole, G. Bormans, and K. V. Laere, Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study, Eur. J. Nucl. Med. Mol. Imaging, vol.40, pp.1582-1594, 2013.

N. V. Chandrasekharan, H. Dai, K. L. Roos, N. K. Evanson, J. Tomsik et al., , 2002.

, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. U. S. A, vol.99, pp.13926-13931

L. Chang, L. Luo, J. A. Palmer, S. Sutton, S. J. Wilson et al., Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms, Br. J. Pharmacol, vol.148, pp.102-113, 2006.

V. Chapman, The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat, Br. J. Pharmacol, vol.127, pp.1765-1767, 1999.

Z. Cheng, H. L. Fields, and M. M. Heinricher, Brain Res, vol.375, pp.57-65, 1986.

S. M. Chen and H. M. Pan, Spinal Endogenous Acetylcholine Contributes to the Analgesic Effect of Systemic Morphine in Rats, vol.95, pp.525-530, 2001.

T. Chen, R. Hui, X. Wang, T. Zhang, Y. Dong et al., Origins of endomorphinimmunoreactive fibers and terminals in different columns of the periaqueductal gray in the rat, J. Comp. Neurol, vol.509, pp.72-87, 2008.

Y. L. Chen, A. H. Li, T. H. Yeh, A. H. Chou, Y. S. Weng et al., Nocistatin excites rostral agranular insular cortex-periaqueductal gray projection neurons by enhancing transient receptor potential cation conductance via G(alphaq/11)-PLCprotein kinase C pathway, Neuroscience, vol.168, pp.226-239, 2010.
DOI : 10.1016/j.neuroscience.2010.03.054

C. Chin, A. E. Tovcimak, V. P. Hradil, T. R. Seifert, P. R. Hollingsworth et al., Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI, Br. J. Pharmacol, vol.153, pp.367-379, 2008.

L. Chiou, S. S. Hu, and Y. Ho, Targeting the cannabinoid system for pain relief?, Acta Anaesthesiol. Taiwan, vol.51, pp.161-170, 2013.
DOI : 10.1016/j.aat.2013.10.004

URL : https://doi.org/10.1016/j.aat.2013.10.004

L. Chiou, H. Lee, Y. Ho, S. Chen, Y. Y. Liao et al., Orexins/hypocretins: pain regulation and cellular actions, Curr. Pharm. Des, vol.16, pp.3089-3100, 2010.
DOI : 10.2174/138161210793292483

D. Chou, E. Abalos, G. M. Gyte, and A. M. Gülmezoglu, Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period, Cochrane Database Syst. Rev. CD008407, 2010.

R. Chou, A. Qaseem, V. Snow, D. Casey, J. T. Cross et al., Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society, Ann. Intern. Med, vol.147, pp.478-491, 2007.

P. J. Christo and D. Mazloomdoost, Cancer pain and analgesia, Ann. N. Y. Acad. Sci, vol.1138, pp.278-298, 2008.

J. R. Clapper, G. Moreno-sanz, R. Russo, A. Guijarro, F. Vacondio et al., , 2010.

, Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism, Nat. Neurosci, vol.13, pp.1265-1270

S. P. Clissold, Paracetamol and phenacetin, Drugs, vol.32, pp.46-59, 1986.
DOI : 10.2165/00003495-198600324-00005

C. Cohen, G. Perrault, C. Voltz, R. Steinberg, and P. Soubrié, SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats, Behav. Pharmacol, vol.13, pp.451-463, 2002.

Z. D. Cooper, S. D. Comer, and M. Haney, Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.38, pp.1984-1992, 2013.

B. Costa, I. Bettoni, S. Petrosino, F. Comelli, G. Giagnoni et al., The dual fatty acid amide hydrolase/TRPV1 blocker, Narachidonoyl-serotonin, relieves carrageenaninduced inflammation and hyperalgesia in mice, Pharmacol. Res, vol.61, pp.537-546, 2010.

B. Costa, D. Siniscalco, A. E. Trovato, F. Comelli, M. L. Sotgiu et al., AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain, Br. J. Pharmacol, vol.148, pp.1022-1032, 2006.

J. P. Courade, F. Caussade, K. Martin, D. Besse, C. Delchambre et al., Effects of acetaminophen on monoaminergic systems in the rat central nervous system, Naunyn. Schmiedebergs Arch. Pharmacol, vol.364, pp.534-537, 2001.

B. F. Cravatt, K. Demarest, M. P. Patricelli, M. H. Bracey, D. K. Giang et al., , 2001.

, Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc. Natl. Acad. Sci, vol.98, pp.9371-9376

B. F. Cravatt and A. H. Lichtman, The endogenous cannabinoid system and its role in nociceptive behavior, J. Neurobiol, vol.61, pp.149-160, 2004.

B. F. Cravatt, A. Saghatelian, E. G. Hawkins, A. B. Clement, M. H. Bracey et al., Functional disassociation of the central and peripheral fatty acid amide signaling systems, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.10821-10826, 2004.

B. Crawley, O. Saito, S. Malkmus, B. Fitzsimmons, X. Hua et al., Acetaminophen prevents hyperalgesia in central pain cascade, Neurosci. Lett. Neuroscience letters, pp.50-53, 2008.

L. Cristino, L. Petrocellis, P. De, G. Baker, D. Guglielmotti et al., , 2006.

, Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain, Neuroscience, vol.139, pp.1405-1415

M. Cui, Y. Feng, D. J. Mcadoo, W. , and W. D. , Periaqueductal Gray Stimulation-Induced Inhibition of Nociceptive Dorsal Horn Neurons in Rats Is Associated with the Release of Norepinephrine, Serotonin, and Amino Acids, J. Pharmacol. Exp. Ther, vol.289, pp.868-876, 1999.

R. Dalmann, L. Daulhac, M. Antri, A. Eschalier, and C. Mallet, Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context, Neuropharmacology, vol.91, p.63, 2014.

D. Daly, W. Rong, R. Chess-williams, C. Chapple, G. et al., Bladder afferent sensitivity in wild-type and TRPV1 knockout mice, J. Physiol, vol.583, pp.663-674, 2007.

R. A. Dampney, T. M. Furlong, J. Horiuchi, and K. Iigaya, Role of dorsolateral periaqueductal grey in the coordinated regulation of cardiovascular and respiratory function, Auton. Neurosci, vol.175, pp.17-25, 2013.

M. Dani, J. Guindon, C. Lambert, and P. Beaulieu, The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors, Eur. J. Pharmacol, vol.573, pp.214-215, 2007.

R. C. Dart, A. R. Erdman, K. R. Olson, G. Christianson, A. S. Manoguerra et al., , 2006.

, Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management, Clin. Toxicol. Phila. Pa, vol.44, pp.1-18

D. Josephy and P. , The molecular toxicology of acetaminophen, Drug Metab. Rev, vol.37, pp.581-594, 2005.

N. M. Davies, R. L. Good, K. A. Roupe, Y. , and J. A. , Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?-Not as easy as 1, 2, 3, J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Société Can. Sci. Pharm, vol.7, pp.217-226, 2004.

J. B. Davis, J. Gray, M. J. Gunthorpe, J. P. Hatcher, P. T. Davey et al., Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia, Nature, vol.405, pp.183-187, 2000.

E. Denes, M. Amaniou, J. Rogez, P. Weinbreck, M. et al., , 2002.

A. , Médecine Interne, vol.153, pp.411-413

A. Depaulis, K. A. Keay, and R. Bandler, Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray region of the rat, Exp. Brain Res, vol.90, pp.307-318, 1992.

J. Descoeur, V. Pereira, A. Pizzoccaro, A. Francois, B. Ling et al., Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors, EMBO Mol. Med, vol.3, pp.266-278, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00731456

D. G. Deutsch, N. Ueda, Y. , and S. , The fatty acid amide hydrolase (FAAH), 2002.

, Prostaglandins Leukot. Essent. Fatty Acids, vol.66, pp.201-210

W. A. Devane, F. A. Dysarz, M. R. Johnson, L. S. Melvin, and A. C. Howlett, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol, vol.34, pp.605-613, 1988.

W. A. Devane, L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson et al., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, vol.258, pp.1946-1949, 1992.

M. Devilliers, J. Busserolles, S. Lolignier, E. Deval, V. Pereira et al., Activation of TREK-1 by morphine results in analgesia without adverse side effects, Nat. Commun, vol.4, p.2941, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01689367

C. N. Dewall, G. Macdonald, G. D. Webster, C. L. Masten, R. F. Baumeister et al., Acetaminophen reduces social pain: behavioral and neural evidence, Psychol. Sci, vol.21, pp.931-937, 2010.

A. Dhaka, V. Viswanath, P. , and A. , , 2006.

, Trp Ion Channels and Temperature Sensation, Annu. Rev. Neurosci, vol.29, pp.135-161

J. E. Dinchuk, R. Q. Liu, and J. M. Trzaskos, , 2003.

, COX-3: in the wrong frame in mind, Immunol. Lett, vol.86, p.121

S. Diochot, A. Baron, M. Salinas, D. Douguet, S. Scarzello et al., Black mamba venom peptides target acid-sensing ion channels to abolish pain, Nature, vol.490, pp.552-555, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02115775

D. W. Dippel, E. J. Breda, . Van, H. B. Worp, . Van-der et al., Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial, BMC Cardiovasc. Disord, vol.3, issue.2, 2003.

A. Dogrul, L. R. Gardell, M. H. Ossipov, F. C. Tulunay, J. Lai et al., Reversal of experimental neuropathic pain by T-type calcium channel blockers, Pain, vol.105, pp.159-168, 2003.

, Disinhibition in a Midbrain Descending Analgesic Pathway, J. Neurosci, vol.29, pp.7220-7229

G. M. Drew, V. A. Mitchell, and C. W. Vaughan, Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling, J. Neurosci, vol.28, pp.808-815, 2008.

R. N. Dubois, S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon et al., , 1998.

, Cyclooxygenase in biology and disease, FASEB J, vol.12, pp.1063-1073

S. T. Duggan and L. J. Scott, Intravenous Paracetamol (Acetaminophen). Drugs, vol.69, pp.101-113, 2009.

E. Dujardin, J. , and U. , Afferents of vocalization-controlling periaqueductal regions in the squirrel monkey, Brain Res, vol.1034, pp.114-131, 2005.

F. Eippert, U. Bingel, E. D. Schoell, J. Yacubian, R. Klinger et al., Activation of the opioidergic descending pain control system underlies placebo analgesia, Neuron, vol.63, pp.533-543, 2009.

R. J. Ellis, W. Toperoff, F. Vaida, G. Brande, . Van-den et al., Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, 2009.

, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.34, pp.672-680

L. Engström-ruud, D. B. Wilhelms, A. Eskilsson, A. M. Vasilache, L. Elander et al., Acetaminophen reduces lipopolysaccharideinduced fever by inhibiting cyclooxygenase-2, Neuropharmacology, vol.71, pp.124-129, 2013.

A. Ericson, E. M. Nur, F. Petersson, and S. Kechagias, The Effects of Capsaicin on Gastrin Secretion in Isolated Human Antral Glands: Before and After Ingestion of Red Chilli, Dig. Dis. Sci, vol.54, pp.491-498, 2009.

V. Erspamer, Arch. Ital. Sci. Farmacol, vol.2, pp.243-245, 1952.

A. I. Fathelrahman, A. F. Rahman, M. Ab, and Z. Zain, Self-poisoning by drugs and chemicals: variations in demographics, associated factors and final outcomes, Gen. Hosp. Psychiatry, vol.30, pp.467-470, 2008.

D. Fegley, S. Kathuria, R. Mercier, C. Li, A. Goutopoulos et al., , 2004.

, Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.8756-8761

R. A. Ferrari, S. J. Ward, C. M. Zobre, D. K. Liew, . Van et al., , 1990.

, Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain, Eur. J. Pharmacol, vol.179, pp.25-34

S. H. Ferreira, B. B. Lorenzetti, and F. M. Correa, Blockade of central and peripheral generation of prostaglandins explains the antialgic effect of aspirin like drugs, Pol J Pharmacol Pharm, vol.30, pp.133-173, 1978.

J. M. Flanagan, A. L. Gerber, J. L. Cadet, E. Beutler, and J. C. Sipe, The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction, Hum. Genet, vol.120, pp.581-588, 2006.

S. J. Flatters and G. J. Bennett, Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy, Pain, vol.109, pp.150-161, 2004.

R. J. Flower and J. R. Vane, Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol), Nature, vol.240, pp.410-411, 1972.

G. Forde, Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles, J. Fam. Pract, vol.56, pp.3-12, 2007.

C. J. Fowler, Anandamide uptake explained?, Trends Pharmacol. Sci, vol.33, pp.181-185, 2012.

C. J. Fowler, S. Holt, O. Nilsson, K. Jonsson, G. Tiger et al., The endocannabinoid signaling system: Pharmacological and therapeutic aspects, Pharmacol. Biochem. Behav, vol.81, pp.248-262, 2005.

C. J. Fowler, J. , and S. O. , Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide-targets for drug development?, Prostaglandins Leukot. Essent. Fatty Acids, vol.66, pp.193-200, 2002.

C. J. Fowler, G. Tiger, A. Ligresti, M. L. López-rodr??guez, V. Marzo et al., Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle, Eur. J. Pharmacol, vol.492, pp.1-11, 2004.

A. Francois, N. Kerckhove, M. Meleine, A. Alloui, C. Barrere et al., State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects, PAIN, vol.154, pp.283-293, 2013.

A. François, N. Schüetter, S. Laffray, J. Sanguesa, A. Pizzoccaro et al., The LowThreshold Calcium Channel Cav3.2 Determines LowThreshold Mechanoreceptor Function, Cell Rep, vol.10, pp.370-382, 2015.

T. F. Freund, I. Katona, P. , and D. , Role of Endogenous Cannabinoids in Synaptic Signaling, Physiol. Rev, vol.83, pp.1017-1066, 2003.

M. Fukuda, K. Kitaichi, F. Abe, Y. Fujimoto, K. Takagi et al., Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice, J. Pharmacol. Sci, vol.97, pp.525-532, 2005.

J. H. Gaddum and Z. P. Picarelli, Two kinds of tryptamine receptor, Br. J. Pharmacol. Chemother, vol.12, p.323, 1957.

S. Gaetani, V. Cuomo, P. , and D. , , 2003.

, Anandamide hydrolysis: a new target for anti-anxiety drugs?, Trends Mol. Med, vol.9, pp.474-478

S. Galiègue, S. Mary, J. Marchand, D. Dussossoy, D. Carrière et al., Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations, Eur. J. Biochem, vol.232, pp.54-61, 1995.

K. Gao, M. , and P. , Serotonergic Raphe Magnus Cells That Respond to Noxious Tail Heat Are Not on or off Cells, J. Neurophysiol, vol.84, pp.1719-1725, 2000.

K. Gao, M. , and P. , Physiological and anatomic evidence for functional subclasses of serotonergic raphe magnus cells, J. Comp. Neurol, vol.439, pp.426-439, 2001.

N. R. Gavva, A. W. Bannon, S. Surapaneni, D. N. Hovland, S. G. Lehto et al., The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation, J. Neurosci, vol.27, pp.3366-3374, 2007.

B. G. Gazzard, A. W. Ford-hutchinson, M. J. Smith, W. , and R. , The binding of paracetamol to plasma proteins of man and pig, J. Pharm. Pharmacol, vol.25, pp.964-967, 1973.

G. F. Gebhart, Opiate and opioid peptide effects on brain stem neurons: Relevance to nociception and antinociceptive mechanisms, Pain, vol.12, pp.93-140, 1982.

G. F. Gebhart, J. Sandkuhler, J. G. Thalhammer, and M. Zimmermann, Inhibition of spinal nociceptive information by stimulation in midbrain of the cat is blocked by lidocaine microinjected in nucleus raphe magnus and medullary reticular formation, J. Neurophysiol, vol.50, pp.1446-1459, 1983.

C. M. Gérard, C. Mollereau, G. Vassart, and M. Parmentier, Molecular cloning of a human cannabinoid receptor which is also expressed in testis, Biochem. J, vol.279, p.129, 1991.

C. Gerin, J. Teilhac, K. Smith, P. , and A. , Motor activity induces release of serotonin in the dorsal horn of the rat lumbar spinal cord, Neurosci. Lett, vol.436, pp.91-95, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00349499

A. Giuffrida, M. Beltramo, P. , and D. , Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology, J. Pharmacol. Exp. Ther, vol.298, pp.7-14, 2001.

A. Giuffrida, F. Rodriguez-de-fonseca, F. Nava, P. Loubet-lescoulié, P. et al., Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404, Eur. J. Pharmacol, vol.408, pp.161-168, 2000.

S. T. Glaser, S. J. Gatley, G. , and A. N. , Ex Vivo Imaging of Fatty Acid Amide Hydrolase Activity and Its Inhibition in the Mouse Brain, J. Pharmacol. Exp. Ther, vol.316, pp.1088-1097, 2006.

G. Gobbi, F. R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo et al., , 2005.

, Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.18620-18625

L. Godfrey, L. Yan, G. D. Clarke, C. Ledent, I. Kitchen et al., Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice, Eur. J. Pharmacol, vol.531, pp.80-86, 2006.

L. Gonçalves, A. Almeida, and A. Pertovaara, Eur. J. Neurosci, vol.26, pp.2188-2195, 2007.

S. González, J. Romero, R. Miguel, . De, I. Lastresbecker et al., Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide, Life Sci, vol.65, pp.327-336, 1999.

G. G. Gould, A. Seillier, G. Weiss, A. Giuffrida, T. F. Burke et al., , 2012.

, Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.38, pp.260-269

G. G. Graham, M. J. Davies, R. O. Day, A. Mohamudally, and K. F. Scott, The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings, Inflammopharmacology, vol.21, pp.201-232, 2013.

G. G. Graham and K. F. Scott, Mechanism of action of paracetamol, Am. J. Ther, vol.12, pp.46-55, 2005.

A. M. Gray, E. Pounds-cornish, F. J. Eccles, T. Z. Aziz, A. L. Green et al., Deep brain stimulation as a treatment for neuropathic pain: a longitudinal study addressing neuropsychological outcomes, J. Pain Off. J. Am. Pain Soc, vol.15, pp.283-292, 2014.

A. L. Green, S. Wang, R. G. Bittar, S. L. Owen, D. J. Paterson et al., Deep brain stimulation: a new treatment for hypertension?, J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas, vol.14, pp.592-595, 2007.

A. L. Green, S. Wang, S. L. Owen, D. J. Paterson, J. F. Stein et al., Controlling the heart via the brain: a potential new therapy for orthostatic hypotension, Neurosurgery, vol.58, pp.1176-1183, 2006.

A. L. Green, S. Wang, S. L. Owen, K. Xie, R. G. Bittar et al., Stimulating the human midbrain to reveal the link between pain and blood pressure, Pain, vol.124, pp.349-359, 2006.

A. L. Green, S. Wang, S. L. Owen, K. Xie, X. Liu et al., Deep brain stimulation can regulate arterial blood pressure in awake humans, Neuroreport, vol.16, pp.1741-1745, 2005.

L. C. Gregg, K. Jung, J. M. Spradley, R. Nyilas, R. L. Suplita et al., Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-? Initiates 2Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia, J. Neurosci, vol.32, pp.9457-9468, 2012.

A. P. Guimarães, F. S. Guimarães, and W. A. Prado, Modulation of carbachol-induced antinociception from the rat periaqueductal gray, Brain Res. Bull, vol.51, pp.471-478, 2000.

J. Guindon, J. Desroches, and P. Beaulieu, , 2007.

, The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors, Br. J. Pharmacol, vol.150, pp.693-701

J. Guindon, Y. Lai, S. M. Takacs, H. B. Bradshaw, and A. G. Hohmann, Alterations in endocannabinoid tone following chemotherapyinduced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment, Pharmacol. Res, vol.67, pp.94-109, 2013.

D. Gunnell, K. Hawton, V. Murray, R. Garnier, C. Bismuth et al., Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified?, J. Epidemiol. Community Health, vol.51, pp.175-179, 1997.

T. J. Haley and W. G. Mccormick, Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse, Br. J. Pharmacol. Chemother, vol.12, p.12, 1957.

V. L. Haller, D. L. Cichewicz, W. , and S. P. , , 2006.

, Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice, Eur J Pharmacol, vol.546, pp.60-68

K. E. Hamlin and F. E. Fischer, THE SYNTHESIS OF 5-HYDROXYTRYPTAMINE, J. Am. Chem. Soc, vol.73, pp.5007-5008, 1951.

D. L. Hammond, G. M. Tyce, Y. , and T. L. , Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla, J. Physiol, vol.359, pp.151-162, 1985.

B. Han, R. Wright, A. M. Kirchhoff, J. A. Chester, B. R. Cooper et al., , 2013.

L. Quantitative, MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor, Anal. Biochem, vol.432, pp.74-81

A. M. Hanel and W. E. Lands, Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides, Biochem. Pharmacol, vol.31, pp.3307-3311, 1982.
DOI : 10.1016/0006-2952(82)90565-2

P. J. Harvison, R. W. Egan, P. H. Gale, G. D. Christian, B. S. Hill et al., Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase, Chem. Biol. Interact, vol.64, pp.251-266, 1988.
DOI : 10.1016/0009-2797(88)90101-9

P. Hasanein, The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis, Neurosci. Lett, vol.462, pp.230-234, 2009.
DOI : 10.1016/j.neulet.2009.07.026

P. Hasanein and N. Soltani, Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats, Clin. Exp. Pharmacol. Physiol, vol.36, pp.1127-1131, 2009.

K. Hawton, H. Bergen, S. Simkin, S. Dodd, P. Pocock et al., Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses, BMJ, vol.346, pp.403-403, 2013.

E. Hazai, L. Vereczkey, and K. Monostory, Reduction of Toxic Metabolite Formation of Acetaminophen, Biochem. Biophys. Res. Commun, vol.291, pp.1089-1094, 2002.
DOI : 10.1006/bbrc.2002.6541

R. C. Heading, J. Nimmo, L. F. Prescott, and P. Tothill, The dependence of paracetamol absorption on the rate of gastric emptying, Br. J. Pharmacol, vol.47, pp.415-421, 1973.

Z. Hegyi, G. Kis, K. Holló, C. Ledent, A. et al., Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord, Eur. J. Neurosci, vol.30, pp.251-262, 2009.

M. M. Heinricher and S. L. Ingram, 41-The Brainstem and Nociceptive Modulation, The Senses: A Comprehensive Reference, vol.5, 2008.
DOI : 10.1016/b978-012370880-9.00183-3

R. H. Albright and . Masland, , pp.593-626

M. M. Heinricher, I. Tavares, J. L. Leith, and B. M. Lumb, Descending control of nociception: Specificity, recruitment and plasticity, Brain Res. Rev, vol.60, pp.214-225, 2009.

L. C. Hendershot and J. Forsaith, Antagonism of the Frequency of Phenylquinone-Induced REFERENCES 215, 1959.

, Writhing in the Mouse by Weak Analgesics and Nonanalgesics, J. Pharmacol. Exp. Ther, vol.125, pp.237-240

A. J. Henderson and S. O. Shaheen, , 2013.

. Acetaminophen, Paediatr. Respir. Rev, vol.14, pp.9-16

M. Herkenham, A. B. Lynn, M. R. Johnson, L. S. Melvin, B. Costa et al., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci, vol.11, pp.563-583, 1991.

I. Heyman and H. P. Rang, Depolarizing responses to capsaicin in a subpopulation of rat dorsal root ganglion cells, Neurosci. Lett, vol.56, pp.69-75, 1985.

O. Hinsberg, Ueber die physiologische Wirkung des p-Aminophenols und einiger Derivate desselben, Naunyn Schmiedebergs Arch. Für Exp. Pathol. Pharmakol, pp.216-50, 1894.

B. Hinz and K. Brune, Paracetamol and Cyclooxygenase Inhibition: Is There a Cause for Concern?, Ann. Rheum. Dis, vol.71, pp.20-25, 2012.

M. C. Hochberg, R. D. Altman, K. T. April, M. Benkhalti, G. Guyatt et al., American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee, Arthritis Care Res, vol.64, pp.465-474, 2012.

E. D. Hogestatt, B. A. Jonsson, A. Ermund, D. A. Andersson, H. Bjork et al., Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system, J Biol Chem, vol.280, pp.31405-31417, 2005.

E. D. Högestätt, B. A. Jönsson, A. Ermund, D. A. Andersson, H. Björk et al., Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system, J. Biol. Chem, vol.280, pp.31405-31412, 2005.

A. G. Hohmann, J. N. Farthing, A. M. Zvonok, and A. Makriyannis, Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin, J. Pharmacol. Exp. Ther, vol.308, pp.446-453, 2004.

A. G. Hohmann and M. Herkenham, Cannabinoid receptors undergo axonal flow in sensory nerves, Neuroscience, vol.92, pp.1171-1175, 1999.

A. G. Hohmann and R. L. Suplita, Endocannabinoid mechanisms of pain modulation, AAPS J, vol.8, pp.693-708, 2006.

A. G. Hohmann, R. L. Suplita, N. M. Bolton, M. H. Neely, D. Fegley et al., An endocannabinoid mechanism for stress-induced analgesia, Nature, vol.435, pp.1108-1112, 2005.

A. G. Hohmann, K. Tsou, and J. M. Walker, Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55, Neurosci. Lett, vol.257, pp.119-122, 1998.

P. Holzer, TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia, Eur. J. Pharmacol, vol.500, pp.231-241, 2004.

P. Holzer, Taste Receptors in the Gastrointestinal Tract. V. Acid sensing in the gastrointestinal tract, Am. J. Physiol.-Gastrointest. Liver Physiol, vol.292, pp.699-705, 2007.

P. Holzer, Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system, Pharmacol. Ther, vol.131, pp.142-170, 2011.

S. Hong, W. , and J. W. , Early Painful Diabetic Neuropathy Is Associated with Differential Changes in the Expression and Function of Vanilloid Receptor 1, J. Biol. Chem, vol.280, pp.618-627, 2005.

T. L. Horvath, C. Peyron, S. Diano, A. Ivanov, G. Astonjones et al., Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system, J. Comp. Neurol, vol.415, pp.145-159, 1999.

Y. Ho, J. Cheng, and L. Chiou, , 2013.

, Hypofunction of Glutamatergic Neurotransmission in the Periaqueductal Gray Contributes to NerveInjury-Induced Neuropathic Pain, J. Neurosci, vol.33, pp.7825-7836

Y. Ho, H. Lee, L. Tung, Y. Liao, S. Fu et al., Activation of Orexin 1 Receptors in the Periaqueductal Gray of Male Rats Leads to Antinociception via Retrograde Endocannabinoid (2-Arachidonoylglycerol)-Induced Disinhibition, J. Neurosci. Off. J. Soc. Neurosci, vol.31, pp.14600-14610, 2011.

D. Hoyer, J. P. Hannon, M. , and G. R. , , 2002.

, Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacol. Biochem. Behav, vol.71, pp.533-554

S. S. Hu, Y. Ho, and L. Chiou, No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids, Eur. J. Neurosci, vol.39, pp.467-484, 2014.

F. J. Israel, G. Parker, M. Charles, R. , and L. , Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial, J. Pain Symptom Manage, vol.39, pp.548-554, 2010.

A. S. Jaggi and N. Singh, Role of different brain areas in peripheral nerve injury-induced neuropathic pain, Brain Res, vol.1381, pp.187-201, 2011.

A. Jarrahian, S. Manna, W. S. Edgemond, W. B. Campbell, H. et al., Structure-Activity Relationships Among N-Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter, J. Neurochem, vol.74, pp.2597-2606, 2000.

A. Jayamanne, R. Greenwood, V. A. Mitchell, S. Aslan, D. Piomelli et al., Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models, Br. J. Pharmacol, vol.147, pp.281-288, 2006.

H. Jeong, D. Chenu, E. E. Johnson, M. Connor, and C. W. Vaughan, Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey, Mol. Pain, vol.4, p.54, 2008.

H. Jeong, K. Lam, V. A. Mitchell, and C. W. Vaughan, Serotonergic modulation of neuronal activity in rat midbrain periaqueductal gray, J. Neurophysiol, vol.109, pp.2712-2719, 2013.

M. D. Jhaveri, D. Richardson, and V. Chapman, Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain, Br. J. Pharmacol, vol.152, pp.624-632, 2007.

J. R. Johnson, M. Burnell-nugent, D. Lossignol, E. D. Ganae-motan, R. Potts et al., Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancerrelated pain, J. Pain Symptom Manage, vol.39, pp.167-179, 2010.

P. L. Johnson, S. L. Lightman, and C. A. Lowry, A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic, Ann. N. Y. Acad. Sci, vol.1018, pp.58-64, 2004.

P. G. Jones and J. Dunlop, Targeting the cholinergic system as a therapeutic strategy for the treatment of pain, Neuropharmacology, vol.53, pp.197-206, 2007.

R. L. Jones, Functions of prostaglandins, Pathobiol. Annu, vol.2, pp.359-380, 1972.

Y. Jo, Y. J. Chen, S. C. Chua, D. A. Talmage, and L. W. Role, Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit, Neuron, vol.48, pp.1055-1066, 2005.

J. S. Jung, D. K. Song, H. W. Suh, K. , and Y. H. , Effects of intraventricular injection of morphine and beta-endorphin on serotonin release from the spinal cord in rats, Pharmacol. Biochem. Behav, vol.49, pp.1037-1042, 1994.

J. Kalliomäki, P. Annas, K. Huizar, C. Clarke, A. Zettergren et al., Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia, Clin. Exp. Pharmacol. Physiol, vol.40, pp.212-218, 2013.

Y. Kang, U. R. Mbonye, C. J. Delong, M. Wada, and W. L. Smith, Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation, Prog. Lipid Res, vol.46, pp.108-125, 2007.

M. Kano, T. Ohno-shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe, , 2009.

, Control of Synaptic Transmission, Physiol. Rev, vol.89, pp.309-380

U. Karlsson, A. K. Sundgren-andersson, S. Johansson, and J. J. Krupp, Capsaicin augments synaptic transmission in the rat medial preoptic nucleus, Brain Res, vol.1043, pp.1-11, 2005.

M. Karst and S. Wippermann, Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective, Expert Opin. Investig. Drugs, vol.18, pp.125-133, 2009.

S. Kathuria, S. Gaetani, D. Fegley, F. Valiño, A. Duranti et al., Modulation of anxiety through blockade of anandamide hydrolysis, Nat. Med, vol.9, pp.76-81, 2003.

M. Kato, K. Taguchi, Y. Hagiwara, and T. Kubo, Effects of electrical stimulation and morphine microinjection into periaqueductal gray on 5-hydroxyindole oxidation current in spinal cord of cats, Gen. Pharmacol. Vasc. Syst, vol.27, pp.1195-1201, 1996.

J. A. Kauer and H. E. Gibson, Hot flash: TRPV channels in the brain, Trends Neurosci, vol.32, pp.215-239, 2009.

H. Kawahara, G. Drew, M. Christie, and C. Vaughan, Inhibition of fatty acid amide hydrolase unmasks CB(1) receptor and TRPV1 channelmediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey, Br. J. Pharmacol, vol.163, pp.1214-1222, 2011.

T. Kawamata, K. Omote, M. Toriyabe, M. Kawamata, and A. Namiki, Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord, Anesthesiology, vol.96, pp.1175-1182, 2002.

V. Kayser, I. E. Elfassi, B. Aubel, M. Melfort, D. Julius et al., Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/and 5-HTT-/-knock-out male mice, Pain, vol.130, pp.235-248, 2007.

D. Kendall, A. , and S. , Behavioral Neurobiology of the Endocannabinoid System, 2009.

N. Kerckhove, C. Mallet, A. François, M. Boudes, J. Chemin et al., Cav3.2 calcium channels: The key protagonist in the supraspinal effect of paracetamol, PAIN®, vol.155, pp.764-772, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01942942

R. Kikkawa, M. Fujikawa, T. Yamamoto, Y. Hamada, H. Yamada et al., In vivo' hepatotoxicity study of rats in comparison with 'in vitro' hepatotoxicity screening system, J. Toxicol. Sci, vol.31, pp.23-34, 2006.

M. Kimura, S. Saito, and H. Obata, , 2012.

, Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord, Neurosci. Lett, vol.529, pp.70-74

S. G. Kinsey, J. Z. Long, S. T. O'neal, R. A. Abdullah, J. L. Poklis et al., Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain, J. Pharmacol. Exp. Ther, vol.330, pp.902-910, 2009.

S. G. Kinsey, P. S. Naidu, B. F. Cravatt, D. T. Dudley, and A. H. Lichtman, Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice, Pharmacol. Biochem. Behav, vol.99, pp.718-725, 2011.

T. C. Kirkham, C. M. Williams, F. Fezza, and V. D. Marzo, Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, REFERENCES 218 feeding and satiation: stimulation of eating by 2arachidonoyl glycerol, Br. J. Pharmacol, vol.136, pp.550-557, 2002.

B. Kis, J. A. Snipes, T. Isse, K. Nagy, and D. W. Busija, Putative Cyclooxygenase-3 Expression in Rat Brain Cells, J. Cereb. Blood Flow Metab, vol.23, p.1287, 2003.

K. Kishimoto, S. Koyama, A. , and N. , , 2001.

, Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons, Neuropharmacology, vol.41, pp.529-538

J. Z. Klafke, M. A. Silva, . Da, G. Trevisan, M. F. Rossato et al., Involvement of the glutamatergic system in the nociception induced intrathecally for a TRPA1 agonist in rats, Neuroscience, vol.222, pp.136-146, 2012.

H. Knotkova, M. Pappagallo, and A. Szallasi, , 2008.

. Capsaicin, Agonist) therapy for pain relief: farewell or revival?, Clin. J. Pain, vol.24, pp.142-154

M. Kock, . De, J. Eisenach, C. Tong, A. Schmitz et al., Analgesic Doses of Intrathecal but Not Intravenous Clonidine Increase Acetylcholine in Cerebrospinal Fluid in Humans, 1997.

, Anesth. Analg, vol.84, pp.800-803, 1997.

T. Kosaka, A. Miyata, H. Ihara, S. Hara, T. Sugimoto et al., Characterization of the human gene (PTGS2) encoding prostaglandinendoperoxide synthase 2, Eur. J. Biochem, vol.221, pp.889-897, 1994.

T. Laba, J. Brien, M. Fransen, J. , and S. , Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS), BMC Musculoskelet. Disord, vol.14, p.160, 2013.

D. M. Lambert, Les vertus thérapeutiques du cannabis à travers les millénaires, J Pharm Belg, pp.21-29, 2002.

Y. Landry and J. Gies, Pharmacologie-3e édition: Des cibles à la thérapeutique (Dunod), 2014.

S. Latini and F. Pedata, Adenosine in the central nervous system: release mechanisms and extracellular concentrations, J. Neurochem, vol.79, pp.463-484, 2001.

B. K. Lau, G. M. Drew, V. A. Mitchell, and C. W. Vaughan, Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey, Br. J. Pharmacol, 2014.

B. K. Lau and C. W. Vaughan, Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray, Mol. Pharmacol, vol.74, pp.1392-1398, 2008.

B. K. Lau and C. W. Vaughan, Descending modulation of pain: the GABA disinhibition hypothesis of analgesia, Curr. Opin. Neurobiol, vol.29, pp.159-164, 2014.

Y. Lee, H. Kim, J. S. Brahim, J. Rowan, G. Lee et al., Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation, PAIN, vol.129, pp.279-286, 2007.

J. Lei, T. Sun, B. M. Lumb, and H. You, , 2014.

M. L. Leong, M. Gu, R. Speltz-paiz, E. I. Stahura, N. Mottey et al., Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain, J. Neurosci. Off. J. Soc. Neurosci, vol.31, pp.17028-17039, 2011.

M. A. Leonis, E. M. Alonso, K. Im, S. H. Belle, and R. H. Squires, Chronic Acetaminophen Exposure in Pediatric Acute Liver Failure, Pediatrics, vol.131, pp.740-746, 2013.

H. Liao, H. Lee, Y. Ho, and L. Chiou, Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptormediated endocannabinoid retrograde disinhibition, Br. J. Pharmacol, vol.163, pp.330-345, 2011.

F. Libert, J. Bonnefont, E. Bourinet, E. Doucet, A. Alloui et al., Acetaminophen: A Central Analgesic Drug That Involves a Spinal Tropisetron-Sensitive, Non-5-HT3 ReceptorMediated Effect, Mol. Pharmacol, vol.66, pp.728-734, 2004.

A. H. Lichtman, S. A. Cook, M. , and B. R. , Investigation of brain sites mediating cannabinoidinduced antinociception in rats: evidence supporting periaqueductal gray involvement, J. Pharmacol. Exp. Ther, vol.276, pp.585-593, 1996.

A. H. Lichtman, E. G. Hawkins, G. Griffin, and B. F. Cravatt, Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo, J. Pharmacol. Exp. Ther, vol.302, pp.73-79, 2002.

A. H. Lichtman, M. , and B. R. , Spinal and supraspinal components of cannabinoid-induced antinociception, J. Pharmacol. Exp. Ther, vol.258, pp.517-523, 1991.

A. H. Lichtman, C. C. Shelton, T. Advani, and B. F. Cravatt, Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia, Pain, vol.109, pp.319-327, 2004.

D. Li, S. Chen, Y. Pan, A. I. Levey, and H. Pan, Role of presynaptic muscarinic and GABAB receptors in spinal glutamate release and cholinergic analgesia in rats, J. Physiol, vol.543, pp.807-818, 2002.

J. C. Liebeskind, G. Guilbaud, J. M. Besson, and J. L. Oliveras, Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons, Brain Res, vol.50, pp.441-446, 1973.

Z. Liew, B. Ritz, C. Rebordosa, P. Lee, and J. Olsen, Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders, JAMA Pediatr, vol.168, pp.313-320, 2014.

C. Linnman, E. A. Moulton, G. Barmettler, L. Becerra, and D. Borsook, Neuroimaging of the periaqueductal gray: State of the field, 2011.

S. F. Lisboa and F. S. Guimarães, Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray, Neuropharmacology, 2012.

S. F. Lisboa, L. B. Resstel, D. C. Aguiar, and F. S. Guimarães, Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test, Eur. J. Pharmacol, vol.593, pp.73-78, 2008.

F. Liu, X. Qu, X. Ding, J. Cai, H. Jiang et al., Decrease in the descending inhibitory 5-HT system in rats with spinal nerve ligation, Brain Res, vol.1330, pp.45-60, 2010.

J. Liu, A. R. Reid, and J. Sawynok, Antinociception by systemically-administered acetaminophen (paracetamol) involves spinal serotonin 5-HT(7) and adenosine A(1) receptors, as well as peripheral adenosine A(1) receptors, Neurosci. Lett, 2013.

S. Lolignier, M. Amsalem, F. Maingret, F. Padilla, M. Gabriac et al., , 2011.

, Channel Contributes to Mechanical and Heat Pain Hypersensitivity Induced by Subacute and Chronic Inflammation, PLoS ONE, vol.6, p.23083

J. Z. Long, W. Li, L. Booker, J. J. Burston, S. G. Kinsey et al., Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects, Nat. Chem. Biol, vol.5, pp.37-44, 2009.

D. R. Loyd, M. A. Henry, and K. M. Hargreaves, Serotonergic neuromodulation of peripheral nociceptors, Semin. Cell Dev. Biol, vol.24, pp.51-57, 2013.

D. R. Loyd, M. M. Morgan, M. , and A. Z. , the male rat: a potential mechanism for sex differences in antinociception, Neuroscience, vol.147, pp.456-468, 2007.

J. S. Lubel, P. W. Angus, and P. J. Gow, , 2007.

, Accidental paracetamol poisoning, Med. J. Aust, vol.186

A. Luchicchi, P. , and M. , Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids, Mol. Neurobiol, vol.46, 2012.

A. Macario and M. A. Royal, A Literature Review of Randomized Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute Postoperative Pain, Pain Pract, vol.11, pp.290-296, 2011.

G. C. Machado, C. G. Maher, P. H. Ferreira, M. B. Pinheiro, C. C. Lin et al., Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials, BMJ, vol.350, p.1225, 2015.

K. Mackie, Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System, pp.299-325, 2005.

H. Madeno?lu, M. Kaçmaz, R. Aksu, C. Bicer, G. Yaba et al., Effects of naloxone and flumazenil on antinociceptive action of acetaminophen in rats, Curr. Ther. Res, vol.71, pp.111-117, 2010.

J. K. Mai, P. , and G. , The Human Nervous System, 2011.

S. Maione, T. Bisogno, V. Novellis, . De, E. Palazzo et al., Pharmacol. Exp. Ther, vol.316, pp.969-982, 2006.

S. Maione, I. Marabese, J. Leyva, E. Palazzo, V. Novellis et al., , 1998.

, Characterisation of mGluRs which modulate nociception in the PAG of the mouse, Neuropharmacology, vol.37, pp.1475-1483

S. Maione, I. Marabese, P. Oliva, V. Novellis, . De et al., Periaqueductal gray matter glutamate and GABA decrease following subcutaneous formalin injection in rat, Neuroreport, vol.10, pp.1403-1407, 1999.

S. Maione, P. Oliva, I. Marabese, E. Palazzo, F. Rossi et al., Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception, Pain, vol.85, pp.183-189, 2000.

S. Maione, E. Palazzo, V. Novellis, . De, L. Stella et al., Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter, Naunyn. Schmiedebergs Arch. Pharmacol, vol.358, pp.411-417, 1998.

C. Mallet, D. A. Barrière, A. Ermund, B. A. Jönsson, A. Eschalier et al., TRPV1 in brain is involved in acetaminopheninduced antinociception, PloS One, vol.5, 2010.

C. Mallet, D. A. Barrière, and A. Eschalier, Le paracétamol : un ancêtre plein d'avenir, Thérapie, vol.67, pp.277-281, 2012.

C. Mallet, L. Daulhac, J. Bonnefont, C. Ledent, M. Etienne et al., Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia, Pain, vol.139, pp.190-200, 2008.

G. Marsicano and B. Lutz, Neuromodulatory functions of the endocannabinoid system, J. Endocrinol. Invest, vol.29, pp.27-46, 2006.

G. Marsicano, C. T. Wotjak, S. C. Azad, T. Bisogno, G. Rammes et al., The endogenous cannabinoid system controls extinction of aversive memories, Nature, vol.418, pp.530-534, 2002.

M. E. Martenson, J. S. Cetas, and M. M. Heinricher, A possible neural basis for stress-induced hyperalgesia, Pain, vol.142, pp.236-244, 2009.

W. J. Martin, N. K. Lai, S. L. Patrick, K. Tsou, and J. M. Walker, Antinociceptive actions of cannabinoids following intraventricular administration in rats, Brain Res, vol.629, pp.300-304, 1993.

V. D. Marzo, M. Bifulco, and L. D. Petrocellis, The endocannabinoid system and its therapeutic exploitation, Nat. Rev. Drug Discov, vol.3, pp.771-784, 2004.

V. D. Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino et al., Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Publ. Online, vol.372, pp.686-691, 1994.

V. Marzo, G. Di, G. Petrocellis, L. De, B. et al., A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid, J. Pharmacol. Exp. Ther, vol.300, pp.984-991, 2002.

L. A. Matsuda, S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Publ. Online, vol.346, pp.561-564, 1990.

A. Mauborgne, H. Poliénor, M. Hamon, F. Cesselin, and S. Bourgoin, Adenosine receptormediated control of in vitro release of pain-related neuropeptides from the rat spinal cord, Eur. J. Pharmacol, vol.441, pp.47-55, 2002.

A. R. Mauger, A. M. Jones, W. , and C. A. , Influence of acetaminophen on performance during time trial cycling, J. Appl. Physiol. Bethesda Md, vol.108, pp.98-104, 1985.

U. R. Mbonye and I. Song, Posttranscriptional and posttranslational determinants of cyclooxygenase expression, BMB Rep, vol.42, pp.552-560, 2009.

S. Mcgaraughty, K. L. Chu, R. S. Bitner, B. Martino, R. E. Kouhen et al., Capsaicin Infused Into the PAG Affects Rat Tail Flick Responses to Noxious Heat and Alters Neuronal Firing in the RVM, J. Neurophysiol, vol.90, pp.2702-2710, 2003.

E. D. Mcnicol, A. Tzortzopoulou, M. S. Cepeda, M. B. Francia, T. Farhat et al., Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and metaanalysis, Br. J. Anaesth, vol.106, pp.764-775, 2011.

R. Mechoulam, S. Ben-shabat, L. Hanus, M. Ligumsky, N. E. Kaminski et al., Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol, vol.50, pp.83-90, 1995.

D. Melck, T. Bisogno, L. Petrocellis, . De, H. Chuang et al., Unsaturated Long-Chain N-Acyl-vanillyl-amides, 1999.

, Vanilloid Receptor Ligands That Inhibit AnandamideFacilitated Transport and Bind to CB1 Cannabinoid Receptors, Biochem. Biophys. Res. Commun, vol.262, pp.275-284

A. Menigoz and M. Boudes, The Expression Pattern of TRPV1 in Brain, J. Neurosci, vol.31, pp.13025-13027, 2011.

E. Mezey, Z. E. Tóth, D. N. Cortright, M. K. Arzubi, J. E. Krause et al., Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human, Proc. Natl. Acad. Sci. U. S. A, vol.97, pp.3655-3660, 2000.

M. Millan, Descending control of pain, Prog. Neurobiol. Progress in neurobiology, pp.355-474, 2002.

D. K. Min, U. I. Tuor, and P. K. Chelikani, Gastric distention induced functional magnetic resonance signal changes in the rodent brain, Neuroscience, vol.179, pp.151-158, 2011.

H. F. Miranda, F. Sierralta, P. , and G. , Neostigmine interactions with non steroidal antiinflammatory drugs, Br. J. Pharmacol, vol.135, pp.1591-1597, 2002.

V. A. Mitchell, R. Greenwood, A. Jayamanne, and C. W. Vaughan, Actions of the Endocannabinoid Transport Inhibitor Am404 in Neuropathic and Inflammatory Pain Models, Clin. Exp. Pharmacol. Physiol, vol.34, pp.1186-1190, 2007.

V. A. Mitchell, H. Jeong, G. M. Drew, and C. W. Vaughan, Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.36, pp.1801-1810, 2011.

V. A. Mitchell, H. Kawahara, and C. W. Vaughan, Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey, J. Physiol, vol.587, pp.2511-2520, 2009.

T. Miyakawa, Y. Terashima, T. Takebayashi, K. Tanimoto, T. Iwase et al., rats. Mol. Pain, vol.10, p.58, 2014.

A. Mohammadi-farani, M. Sahebgharani, Z. Sepehrizadeh, E. Jaberi, and M. Ghazi-khansari, Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray, Brain Res, vol.1328, pp.49-56, 2010.

C. Montell, The TRP Superfamily of Cation Channels, Sci. Signal, p.3, 2005.

F. A. Moreira, D. C. Aguiar, and F. S. Guimarães, Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray, Neuropharmacology, vol.52, pp.958-965, 2007.

G. Moreno-sanz, B. Barrera, A. Guijarro, I. Elia, J. A. Otero et al., The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system, Pharmacol. Res, vol.64, pp.359-363, 2011.

G. Moreno-sanz, O. Sasso, A. Guijarro, O. Oluyemi, R. Bertorelli et al., Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the bloodplacenta barrier, Br. J. Pharmacol, vol.167, pp.1620-1628, 2012.

M. M. Morgan, E. N. Bobeck, and S. L. Ingram, Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat, Brain Res, vol.1295, pp.59-66, 2009.

M. M. Morgan, R. A. Reid, T. M. Stormann, and N. J. Lautermilch, Opioid Selective Antinociception Following Microinjection into the Periaqueductal Gray of the Rat, J. Pain Off. J. Am. Pain Soc, 2014.

M. M. Morgan, P. K. Whitney, and M. S. Gold, Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray, Brain Res, vol.804, pp.159-166, 1998.

V. Morisset, U. , and L. , CannabinoidInduced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord, J. Neurophysiol, vol.86, pp.40-48, 2001.

C. J. Morris, Carrageenan-induced paw edema in the rat and mouse, Methods Mol. Biol. Clifton NJ, vol.225, pp.115-121, 2003.

H. N. Morse, Ueber eine neue Darstellungsmethode der Acetylamidophenole, Ber Dtsch. Chem Ges, pp.232-233, 1878.

S. Mrozek, J. Constantin, E. Futier, M. Zenut, G. Ghardes et al., , 2009.

. Ann and . Fr, Anesthèsie Rèanimation Annales françaises d'anesthèsie et de rèanimation, pp.448-53

C. P. Muller, J. , and B. , Handbook of the Behavioral Neurobiology of Serotonin, 2009.

E. M. Munn, S. E. Harte, A. Lagman, and G. S. Borszcz, Contribution of the periaqueductal gray to the suppression of pain affect produced by administration of morphine into the intralaminar thalamus of rat, J. Pain Off. J. Am. Pain Soc, vol.10, pp.426-435, 2009.

S. Munro, K. L. Thomas, and M. Abu-shaar, Molecular characterization of a peripheral receptor for cannabinoids, 1993.

, Doi101038365061a0, vol.365, pp.61-65

F. Musshoff, S. Padosch, S. Steinborn, and B. Madea, Fatal blood and tissue concentrations of more than 200 drugs, Forensic Sci. Int, vol.142, pp.161-210, 2004.

U. S. Muth-selbach, I. Tegeder, K. Brune, and G. Geisslinger, Acetaminophen Inhibits Spinal Prostaglandin E2 Release after Peripheral Noxious Stimulation. Anesthesiol, vol.91, pp.231-239, 1999.

P. S. Naidu, S. G. Kinsey, T. L. Guo, B. F. Cravatt, and A. H. Lichtman, Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase, J. Pharmacol. Exp. Ther, vol.334, pp.182-190, 2010.

K. Nakajima, H. Obata, N. Ito, F. Goto, and S. Saito, The nociceptive mechanism of 5hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats, Eur. J. Pain, vol.13, pp.441-447, 2009.

F. A. Nasrallah, J. Tan, C. , and K. , Pharmacological modulation of functional connectivity: ?2-adrenergic receptor agonist alters synchrony but not neural activation, NeuroImage, vol.60, pp.436-446, 2012.

P. Nguyen, D. Selley, and L. Sim-selley, , 2010.

, Statistical Parametric Mapping reveals ligand and region specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain, NeuroImage, vol.52, pp.1243-1251

F. T. Nickel, F. Seifert, S. Lanz, and C. Maihöfner, Mechanisms of neuropathic pain, Eur. Neuropsychopharmacol, vol.22, pp.81-91, 2012.

R. Nieuwenhuys, J. Voogd, C. Huijzen, and . Van, The Human Central Nervous System: A Synopsis and Atlas, 2007.

V. Novellis, . De, L. Mariani, E. Palazzo, D. Vita et al., , 2005.

, Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat, Neuroscience, vol.134, pp.269-281

I. Nozadze, N. Tsiklauri, G. Gurtskaia, E. Abzianidze, and M. G. Tsagareli, Opioid sensitivity of nucleus raphe magnus ater analgesia by nonsteroidal anti-inflammatory drugs, Georgian Med. News, pp.50-55, 2011.

O. Ohno-shosaku, T. Kano, and M. , , 2014.

, Endocannabinoid-mediated retrograde modulation of synaptic transmission, Curr. Opin. Neurobiol, vol.29, pp.1-8

G. Olive, Analgesic/Antipyretic treatment: ibuprofen or acetaminophen? An update, Thérapie, vol.61, pp.151-160, 2006.

M. H. Ossipov, G. O. Dussor, and F. Porreca, Central modulation of pain, J. Clin. Invest, vol.120, pp.3779-3787, 2010.

D. Ost, T. Roskams, F. Van-der, and D. De-ridder, Topography of the Vanilloid Receptor in the Human Bladder: More Than Just the Nerve Fibers, 2002.

, J. Urol, vol.168, pp.293-297, 2002.

A. Ottani, S. Leone, M. Sandrini, A. Ferrari, and A. Bertolini, The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors, Eur. J. Pharmacol, vol.531, pp.280-281, 2006.

M. Ouellet, P. , and M. D. , Mechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms, Arch. Biochem. Biophys, vol.387, pp.273-280, 2001.

R. M. Pabbidi, S. Yu, S. Peng, R. Khardori, M. E. Pauza et al., Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity, Mol. Pain, vol.4, p.9, 2008.

U. Pagotto, G. Marsicano, D. Cota, B. Lutz, P. et al., The emerging role of the endocannabinoid system in endocrine regulation and energy balance, Endocr. Rev, vol.27, pp.73-100, 2006.

E. Palazzo, L. Luongo, G. Bellini, F. Guida, I. Marabese et al., Changes in Cannabinoid Receptor Subtype 1 Activity and Interaction with Metabotropic Glutamate Subtype 5 Receptors in the Periaqueductal Gray-Rostral Ventromedial Medulla Pathway in a Rodent Neuropathic Pain Model, CNS Neurol. Disord. Drug Targets, 2012.

E. Palazzo, L. Luongo, V. Novellis, . De, L. Berrino et al., Moving towards supraspinal TRPV1 receptors for chronic pain relief, Mol. Pain, vol.6, p.66, 2010.

E. Palazzo, L. Luongo, V. Novellis, . De, F. Rossi et al., Transient receptor potential vanilloid type 1 and pain development, Curr. Opin. Pharmacol, 2012.

E. Palazzo, I. Marabese, V. Novellis, . De, P. Oliva et al., Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception, Neuropharmacology, vol.40, pp.319-326, 2001.

E. Palazzo, I. Marabese, V. Novellis, . De, F. Rossi et al., Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond, Eur. J. Neurosci, vol.39, pp.444-454, 2014.

E. Palazzo, V. Novellis, . De, I. Marabese, D. Cuomo et al., Interaction between vanilloid and glutamate receptors in the central modulation of nociception, Eur J Pharmacol, vol.439, pp.69-75, 2002.

E. Palazzo, F. Rossi, M. , and S. , Role of TRPV1 receptors in descending modulation of pain, Mol. Cell. Endocrinol, vol.286, pp.79-83, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00531985

E. Palazzos, V. Novellis, . De, I. Marabese, F. Rossi et al., Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing, Curr. Neuropharmacol, vol.4, pp.225-231, 2006.

M. C. Papadopoulos, G. T. Manley, S. Krishna, and A. S. Verkman, Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.18, pp.1291-1293, 2004.

D. Parolaro, P. Massi, T. Rubino, and E. Monti, Endocannabinoids in the immune system and cancer, Prostaglandins Leukot. Essent. Fatty Acids, vol.66, pp.319-332, 2002.

M. K. Patel, R. D. Pinnock, L. , and K. , , 2001.

, Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord, Brain Res, vol.920, pp.19-26

G. Paxinos, The Rat Nervous System, 2004.

G. Paxinos, The Rat Nervous System, 2014.

S. F. Pedersen, G. Owsianik, and B. Nilius, TRP channels: an overview, Cell Calcium, vol.38, pp.233-252, 2005.

T. Pelissier, A. Alloui, F. Caussade, C. Dubray, A. Cloarec et al., Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence, J. Pharmacol. Exp. Ther, vol.278, pp.8-14, 1996.

T. Pelissier, A. Alloui, C. Paeile, and A. Eschalier, Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors, Neuroreport, vol.6, pp.1546-1548, 1995.

J. Peng, L. , and Y. , The vanilloid receptor TRPV1: Role in cardiovascular and gastrointestinal protection, Eur. J. Pharmacol, vol.627, pp.1-7, 2010.

A. Pertovaara, H. Wei, and M. M. Hämäläinen, Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats, Neurosci. Lett, vol.218, pp.127-130, 1996.

R. G. Pertwee, Pharmacology of cannabinoid CB1 and CB2 receptors, Pharmacol. Ther, vol.74, pp.129-180, 1997.

R. G. Pertwee, Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors, Life Sci, vol.65, pp.597-605, 1999.

R. G. Peterson and B. H. Rumack, Pharmacokinetics of acetaminophen in children, Pediatrics, vol.62, pp.877-879, 1978.

L. D. Petrocellis, T. Bisogno, M. Maccarrone, J. B. Davis, A. Finazzi-agrò et al., The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism, J. Biol. Chem, vol.276, pp.12856-12863, 2001.

L. Petrocellis, . De, V. Marzo, and . Di, Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels, J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol, vol.5, pp.103-121, 2010.

C. Peyron, D. K. Tighe, A. N. Pol, . Van-den, L. Lecea et al., Neurons containing hypocretin (orexin) project to multiple neuronal systems, J. Neurosci. Off. J. Soc. Neurosci, vol.18, pp.9996-10015, 1998.

G. Pickering, V. Estève, M. Loriot, A. Eschalier, and C. Dubray, Acetaminophen reinforces descending inhibitory pain pathways, Clin. Pharmacol. Ther, vol.84, pp.47-51, 2008.

G. Pickering, M. Loriot, F. Libert, A. Eschalier, P. Beaune et al., Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism, Clin. Pharmacol. Ther, vol.79, pp.371-378, 2006.

G. Pickering, N. Macian, F. Libert, J. M. Cardot, S. Coissard et al., Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers, Drug Des. Devel. Ther, vol.8, pp.1621-1627, 2014.

G. Pickering, F. Moustafa, S. Desbrandes, J. M. Cardot, D. Roux et al., Paracetamol and opioid pathways: a pilot randomized clinical trial, Fundam. Clin. Pharmacol, vol.27, pp.339-345, 2013.

C. A. Pierce and B. Voss, Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review, Ann. Pharmacother, vol.44, pp.489-506, 2010.

G. Pinardi, F. Sierralta, M. , and H. F. , Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice, Pharmacol. Biochem. Behav, vol.74, pp.603-608, 2003.

L. A. Pini, M. Sandrini, and G. Vitale, The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain, Eur. J. Pharmacol, vol.308, pp.31-40, 1996.

L. A. Pini, G. Vitale, A. Ottani, and M. Sandrini, Naloxone-Reversible Antinociception by Paracetamol in the Rat, J. Pharmacol. Exp. Ther, vol.280, pp.934-940, 1997.

F. Pinto-ribeiro, D. Amorim, A. David-pereira, A. M. Monteiro, P. Costa et al., Pronociception from the dorsomedial nucleus of the hypothalamus is mediated by the rostral ventromedial medulla in healthy controls but is absent in arthritic animals, Brain Res. Bull, vol.99, pp.100-108, 2013.

M. Pistis, L. Ferraro, L. Pira, G. Flore, S. Tanganelli et al., , 2002.

. Delta, tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study, Brain Res, vol.948, issue.9, pp.155-158

M. Ploner, M. C. Lee, K. Wiech, U. Bingel, T. et al., Prestimulus functional connectivity determines pain perception in humans, Proc. Natl. Acad. Sci, vol.107, pp.355-360, 2010.

L. F. Prescott, Kinetics and metabolism of paracetamol and phenacetin, Br. J. Clin. Pharmacol. REFERENCES, vol.226, 1980.

L. F. Prescott, Paracetamol, alcohol and the liver, Br. J. Clin. Pharmacol, vol.49, pp.291-301, 2000.

L. F. Prescott, Therapeutic misadventure with paracetamol: fact or fiction?, Am. J. Ther, vol.7, pp.99-114, 2000.

M. J. Prior, J. R. Codispoti, and M. Fu, A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache, Headache, vol.50, pp.819-833, 2010.

D. Proudnikov, T. Kroslak, J. C. Sipe, M. Randesi, D. Li et al., Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1, Pharmacogenomics J, vol.10, pp.232-242, 2010.

M. Pytliak, V. Vargová, V. Mechírová, and M. Fel?öci, Serotonin receptors-from molecular biology to clinical applications, Physiol. Res. Acad. Sci. Bohemoslov, vol.60, pp.15-25, 2011.

P. Queneau, La saga du paracétamol, Médecine, vol.2, pp.158-159, 2006.

R. B. Raffa, C. , and E. E. , Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays), Life Sci, vol.59, pp.37-40, 1996.

R. B. Raffa, D. J. Stone, and R. J. Tallarida, Discovery of 'Self-Synergistic' Spinal/Supraspinal Antinociception Produced by Acetaminophen (Paracetamol), J. Pharmacol. Exp. Ther, vol.295, pp.291-294, 2000.

R. B. Raffa, E. A. Walker, and S. N. Sterious, Opioid receptors and acetaminophen (paracetamol), 2004.

, Eur. J. Pharmacol, vol.503, pp.209-210

W. Rahman, K. Bannister, L. A. Bee, and A. H. Dickenson, A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat, Brain Res, vol.1382, pp.29-36, 2011.

W. Rahman, R. Suzuki, M. Webber, S. P. Hunt, and A. H. Dickenson, Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation, PAIN, vol.123, pp.264-274, 2006.

G. Rana, . La, R. Russo, P. Campolongo, M. Bortolato et al., Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404, 2006.

, J. Pharmacol. Exp. Ther, vol.317, pp.1365-1371

M. M. Rapport, A. A. Green, P. , and I. H. , Purification of the substance which is responsible for the vasoconstrictor activity of serum, Fed. Proc, vol.6, p.184, 1947.

M. M. Rapport, A. A. Green, P. , and I. H. , Serum vasoconstrictor, serotonin; isolation and characterization, J. Biol. Chem, vol.176, pp.1243-1251, 1948.

M. H. Rashid, M. Inoue, S. Kondo, T. Kawashima, S. Bakoshi et al., Novel Expression of Vanilloid Receptor 1 on Capsaicin-Insensitive Fibers Accounts for the Analgesic Effect of Capsaicin Cream in Neuropathic Pain, J. Pharmacol. Exp. Ther, vol.304, pp.940-948, 2003.

M. D. Rawlins, D. B. Henderson, and A. R. Hijab, Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration, Eur. J. Clin. Pharmacol, vol.11, pp.283-286, 1977.

S. M. Rawls, Z. Ding, and A. Cowan, Role of TRPV1 and cannabinoid CB1 receptors in AM 404evoked hypothermia in rats, Pharmacol. Biochem. Behav, vol.83, pp.508-516, 2006.

K. Rea, M. Roche, and D. P. Finn, REFERENCES 227 structure, regulation and roles in and beyond endocannabinoid signalling, Philos. Trans. R. Soc. Lond. B. Biol. Sci, vol.152, pp.3264-3275, 2007.

B. Renner, G. Clarke, T. Grattan, A. Beisel, C. Mueller et al., Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen, J. Clin. Pharmacol, vol.47, pp.715-726, 2007.

W. M. Renno, M. A. Mullett, and A. J. Beitz, of the rat, Brain Res, vol.594, pp.221-232, 1992.

L. B. Resstel, S. F. Lisboa, D. C. Aguiar, F. M. Corrêa, and F. S. Guimarães, Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats, 2008.

, Psychopharmacology (Berl.), vol.198, pp.405-411

D. V. Reynolds, Surgery in the rat during electrical analgesia induced by focal brain stimulation, Science, vol.164, pp.444-445, 1969.

R. M. Rezende, D. S. França, G. B. Menezes, W. G. Reis, . Dos et al., Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain, Br. J. Pharmacol, vol.153, pp.760-768, 2008.

A. S. Rice, D. Cimino-brown, J. C. Eisenach, V. K. Kontinen, M. L. Lacroix-fralish et al., Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standards, PAIN, vol.139, pp.243-247, 2008.

A. S. Rice, D. Cimino-brown, J. C. Eisenach, V. K. Kontinen, M. L. Lacroix-fralish et al., Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards, Pain, vol.139, pp.243-247, 2008.

J. D. Richardson, Cannabinoids modulate pain by multiple mechanisms of action, J. Pain, vol.1, pp.2-14, 2000.

J. D. Richardson, L. Aanonsen, and K. M. Hargreaves, Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia, J. Neurosci. Off. J. Soc. Neurosci, vol.18, pp.451-457, 1998.

J. D. Richardson, S. Kilo, and K. M. Hargreaves, Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors, Pain, vol.75, pp.111-119, 1998.
DOI : 10.1016/s0304-3959(97)00213-3

URL : http://www.druglibrary.org/crl/pain/Richardson et.al 98 Hyperalgesia %26 Inflammation_ Pain.pdf

P. Richette, How safe is acetaminophen in rheumatology? Jt, Bone Spine Rev. Rhum, vol.81, pp.4-5, 2014.
DOI : 10.1016/j.jbspin.2013.11.010

E. F. Ring, A. J. Collins, P. A. Bacon, and J. A. Cosh, Quantitation of thermography in arthritis using multi-isothermal analysis. II. Effect of nonsteroidal anti-inflammatory therapy on the thermographic index, Ann. Rheum. Dis, vol.33, pp.353-356, 1974.

J. P. Rivot, C. Y. Chiang, and J. M. Besson, Increase of serotonin metabolism within the dorsal horn of the spinal cord during nucleus raphe magnus stimulation, as revealed by in vivo electrochemical detection, Brain Res, vol.238, pp.117-126, 1982.

J. Robak, A. Wieckowski, G. , and R. , The effect of 4-acetamidophenol on prostaglandin synthetase activity in bovine and ram seminal vesicle microsomes, Biochem. Pharmacol, vol.27, pp.393-396, 1978.

N. Robbins, S. E. Koch, and J. Rubinstein, , 2013.

, Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease, Transl. Res, vol.161, pp.469-476

E. Roberts, V. D. Nunes, S. Buckner, S. Latchem, M. Constanti et al., Paracetamol: not as safe as we thought? A systematic literature review of observational studies, Ann. Rheum. Dis. annrheumdis, 2014.

J. C. Roberts, J. B. Davis, and C. D. Benham, , 2004.

, Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution, Brain Res, vol.995, pp.176-183

L. Robinson, S. Mckillop-smith, N. L. Ross, R. G. Pertwee, R. E. Hampson et al., , 2008.

, Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats, Psychopharmacology (Berl.), vol.198, pp.551-563

A. A. Romanovsky, M. C. Almeida, A. Garami, A. A. Steiner, M. H. Norman et al., The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is Not, Pharmacol. Rev, vol.61, pp.228-261, 2009.

A. Rosén, Y. Zhang, I. Lund, T. Lundeberg, Y. et al., Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration, Brain Res, vol.1001, pp.87-94, 2004.

R. A. Ross, Anandamide and vanilloid TRPV1 receptors, Br. J. Pharmacol, vol.140, pp.790-801, 2003.

M. Rot, S. J. Mathew, and D. S. Charney, Neurobiological mechanisms in major depressive disorder, CMAJ Can. Med. Assoc. J, vol.180, pp.305-313, 2009.

V. Ruggieri, G. Vitale, L. Pini, and M. Sandrini, Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol, Naunyn. Schmiedebergs Arch. Pharmacol, vol.377, pp.219-229, 2008.

B. H. Rumack, Acetaminophen overdose, Am. J. Med, vol.75, pp.104-112, 1983.

E. B. Russo, Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential (Routledge), 2013.

T. Rygnestad, K. Zahlsen, and F. A. Samdal, Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers, Eur. J. Clin. Pharmacol, vol.56, pp.141-143, 2000.

M. Sa?aga, M. Sobczak, and J. Fichna, Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.52, pp.173-179, 2014.

O. Sasso, R. Bertorelli, T. Bandiera, R. Scarpelli, G. Colombano et al., , 2012.

, Peripheral FAAH inhibition causes profound antinociception and protects against indomethacininduced gastric lesions, Pharmacol. Res, vol.65, pp.553-563

P. Savigny, P. Watson, M. Underwood, and G. Development-group, Early management of persistent non-specific low back pain: summary of NICE guidance, BMJ, vol.338, p.1805, 2009.

J. Sawynok, Caffeine and pain, PAIN, vol.152, pp.726-729, 2011.

J. Sawynok, Methylxanthines and Pain, Methylxanthines, pp.311-329, 2011.

J. Sawynok and X. J. Liu, Adenosine in the spinal cord and periphery: release and regulation of pain, Prog. Neurobiol, vol.69, pp.313-340, 2003.

J. Sawynok, R. , and A. R. , Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors, Eur. J. Pharmacol, vol.674, pp.248-254, 2012.

G. C. Scanlon, M. S. Wallace, J. S. Ispirescu, and G. Schulteis, Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans, J. Investig. Med. Off. Publ. Am. Fed. Clin. Res, vol.54, pp.238-244, 2006.

S. Schildknecht, M. Bachschmid, and V. Ullrich, Peroxynitrite provides the peroxide tone for PGHS-2-dependent prostacyclin synthesis in vascular smooth muscle cells, FASEB J, 2005.

S. Schildknecht, A. Daiber, S. Ghisla, R. A. Cohen, and M. M. Bachschmid, Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite, FASEB J, vol.22, pp.215-224, 2008.

J. E. Schlosburg, S. G. Kinsey, and A. H. Lichtman, Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation, AAPS J, vol.11, pp.39-44, 2009.

P. C. Schmid, B. C. Paria, R. J. Krebsbach, H. H. Schmid, and S. K. Dey, Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation, Proc. Natl. Acad. Sci, vol.94, pp.4188-4192, 1997.

S. A. Schnell, W. A. Staines, and M. W. Wessendorf, Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue, J. Histochem. Cytochem. Off. J. Histochem. Soc, vol.47, pp.719-730, 1999.

S. T. Schultz, H. S. Klonoff-cohen, D. L. Wingard, N. A. Akshoomoff, C. A. Macera et al., , 2008.

, Acetaminophen (paracetamol) use, measles-mumpsrubella vaccination, and autistic disorder: the results of a parent survey, Autism Int. J. Res. Pract, vol.12, pp.293-307

R. S. Scotland, S. Chauhan, C. Davis, C. D. Felipe, S. Hunt et al., Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation A Novel Mechanism Involved in Myogenic Constriction, Circ. Res, vol.95, pp.1027-1034, 2004.

A. Sexton, M. Mcdonald, C. Cayla, C. Thiemermann, and A. Ahluwalia, 12-Lipoxygenasederived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1, FASEB J, vol.21, pp.2695-2703, 2007.

M. Seyrek, S. Kahraman, M. S. Deveci, O. Yesilyurt, and A. Dogrul, Systemic cannabinoids produce CB?-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors, Eur. J. Pharmacol, vol.649, pp.183-194, 2010.

S. S. Shaftel, J. A. Olschowka, S. D. Hurley, A. H. Moore, and M. K. Banion, COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells, Mol. Brain Res, vol.119, pp.213-215, 2003.

S. O. Shaheen, J. A. Sterne, C. E. Songhurst, and P. G. Burney, Frequent paracetamol use and asthma in adults, Thorax, vol.55, pp.266-270, 2000.

S. Sheth, R. Brito, D. Mukherjea, L. P. Rybak, R. et al., Adenosine Receptors: Expression, Function and Regulation, Int. J. Mol. Sci, vol.15, pp.2024-2052, 2014.

C. P. Siegers, Effects of caffeine on the absorption and analgesic efficacy of paracetamol in rats, Pharmacology, vol.10, pp.19-27, 1973.

A. Simonnet, M. Cador, C. , and S. , Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area, Addict. Biol, vol.18, pp.930-936, 2013.

H. S. Smith, Potential analgesic mechanisms of acetaminophen, Pain Physician, vol.12, pp.269-280, 2009.

H. S. Smith, Potential analgesic mechanisms of acetaminophen, Pain Physician, vol.12, pp.269-80, 2009.

W. L. Smith, R. M. Garavito, D. , and D. L. , Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and ?2, J. Biol. Chem, vol.271, pp.33157-33160, 1996.

C. A. Snijder, A. Kortenkamp, E. A. Steegers, V. W. Jaddoe, A. Hofman et al., Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study, Hum. Reprod, vol.27, pp.1191-1201, 2012.

J. A. Snipes, B. Kis, G. S. Shelness, J. A. Hewett, and D. W. Busija, Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat, J. Pharmacol. Exp. Ther, vol.313, pp.668-676, 2005.

C. Sommer, Serotonin in pain and analgesia, Mol. Neurobiol, vol.30, pp.117-125, 2004.

M. Soukupová, E. Palazzo, M. Chiaro, . De, L. Gatta et al., Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol, Neuro Endocrinol. Lett, vol.31, pp.507-511, 2010.

S. Sounvoravong, M. N. Nakashima, M. Wada, and K. Nakashima, Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain, Eur. J. Pharmacol, vol.484, pp.217-223, 2004.

M. D. Southall, T. Li, L. S. Gharibova, Y. Pei, G. D. Nicol et al., Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes, 2003.

, J. Pharmacol. Exp. Ther, vol.304, pp.217-222

R. Spiller, Q. Aziz, F. Creed, A. Emmanuel, L. Houghton et al., Guidelines on the irritable bowel syndrome: mechanisms and practical management, Gut, vol.56, pp.1770-1798, 2007.

J. A. Stamford, Descending control of pain, Br. J. Anaesth, vol.75, pp.217-227, 1995.

K. Starowicz, S. Maione, L. Cristino, E. Palazzo, I. Marabese et al., Tonic Endovanilloid Facilitation of Glutamate Release in REFERENCES 230, 2007.

, Brainstem Descending Antinociceptive Pathways, J. Neurosci, vol.27, pp.13739-13749

H. W. Steenland, S. W. Ko, L. Wu, and M. Zhuo, Hot receptors in the brain, Mol. Pain, vol.2, p.34, 2006.

L. T. Stevens and L. , Action of intermittent pressure and of defibrinated blood upon blood vessels of frog and terrapin, Johns Hopkins Biol Stud, 1884.

G. M. Story, The Emerging Role of TRP Channels in Mechanisms of Temperature and Pain Sensation, Curr. Neuropharmacol, vol.4, p.183, 2006.

T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda et al., 2Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain, Biochem. Biophys. Res. Commun, vol.215, pp.89-97, 1995.

R. L. Suplita, J. N. Farthing, T. Gutierrez, and A. G. Hohmann, Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla, Neuropharmacology, vol.49, pp.1201-1209, 2005.

O. A. Al-swayeh, L. E. Futter, R. H. Clifford, M. , and P. K. , Nitroparacetamol exhibits antiinflammatory and anti-nociceptive activity, Br. J. Pharmacol, vol.130, pp.1453-1456, 2000.

T. A. Swierkosz, L. Jordan, M. Mcbride, K. Mcgough, J. Devlin et al., Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit, Med. Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.8, pp.496-503, 2002.

A. Szallasi and P. M. Blumberg, Vanilloid (Capsaicin) Receptors and Mechanisms, Pharmacol. Rev, vol.51, pp.159-212, 1999.

A. Szallasi, D. N. Cortright, C. A. Blum, and S. R. Eid, The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept, Nat. Rev. Drug Discov, vol.6, pp.357-372, 2007.

Y. Takahashi, K. Hashimoto, and S. Tsuji, Successful use of zonisamide for central poststroke pain, J. Pain, vol.5, pp.192-194, 2004.

M. Takemura, D. Quarcoo, A. Niimi, Q. T. Dinh, P. Geppetti et al., Is TRPV1 a useful target in respiratory diseases?, Pulm. Pharmacol. Ther, vol.21, pp.833-839, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00499162

E. M. Talley, L. L. Cribbs, J. Lee, A. Daud, E. Perezreyes et al., Differential Distribution of Three Members of a Gene Family Encoding Low Voltage-Activated (T-Type) Calcium Channels, J. Neurosci, vol.19, pp.1895-1911, 1999.

N. Tamamaki, Y. Yanagawa, R. Tomioka, J. Miyazaki, K. Obata et al., Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse, J. Comp. Neurol, vol.467, pp.60-79, 2003.

B. Tasmacioglu, I. Aydinli, K. Keskinbora, A. F. Pekel, T. Salihoglu et al., Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.17, pp.1475-1481, 2009.

C. Tavares and R. K. Sakata, Caffeine in the treatment of pain, Rev. Bras. Anestesiol, vol.62, pp.387-401, 2012.

A. R. Temple, B. R. Temple, and E. K. Kuffner, Dosing and antipyretic efficacy of oral acetaminophen in children, Clin. Ther, vol.35, pp.1361-1375, 2013.

E. Tiippana, K. Hamunen, V. Kontinen, and E. Kalso, The effect of paracetamol and tropisetron on pain: experimental studies and a review of published data, Basic Clin. Pharmacol. Toxicol, vol.112, pp.124-131, 2013.

T. Tittelboom, G. Van, and M. , Hypothermia: an unusual side effect of paracetamol, Vet. Hum. Toxicol, vol.31, pp.57-59, 1989.

A. Tjølsen, A. Lund, and K. Hole, , 1991.

, Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems, Eur. J. Pharmacol, vol.193, pp.193-201

A. Tjolsen, A. Lund, and K. Hole, , 1991.

, Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems, Eur J Pharmacol, vol.193, pp.193-201

M. Tominaga, C. , and M. J. , , 2004.

, Thermosensation and pain, J. Neurobiol, vol.61, pp.3-12

M. Tominaga, M. J. Caterina, A. B. Malmberg, T. A. Rosen, H. Gilbert et al., The cloned capsaicin receptor integrates multiple painproducing stimuli, Neuron, vol.21, pp.531-543, 1998.

L. Toms, H. J. Mcquay, S. Derry, M. , and R. A. , Single dose oral paracetamol (acetaminophen) for postoperative pain in adults, 2008.

, Cochrane Database Syst. Rev. CD004602

A. Tóth, J. Boczán, N. Kedei, E. Lizanecz, Z. Bagi et al., Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain, Mol. Brain Res, vol.135, pp.162-168, 2005.

K. Toussaint, X. C. Yang, M. A. Zielinski, K. L. Reigle, S. D. Sacavage et al., What do we (not) know about how paracetamol (acetaminophen) works?, J. Clin. Pharm. Ther, vol.35, pp.617-638, 2010.

T. E. Towheed, L. Maxwell, M. G. Judd, M. Catton, M. C. Hochberg et al., , 2006.

, Acetaminophen for osteoarthritis, Cochrane Database Syst. Rev. CD004257

C. Tsatsanis, A. Androulidaki, M. Venihaki, and A. N. Margioris, Signalling networks regulating cyclooxygenase-2, Int. J. Biochem. Cell Biol, vol.38, pp.1654-1661, 2006.

K. Tsou, S. Brown, M. C. Sañudo-peña, K. Mackie, and J. M. Walker, Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, Neuroscience, vol.83, pp.393-411, 1998.

A. Tzortzopoulou, E. D. Mcnicol, M. S. Cepeda, M. B. Francia, T. Farhat et al., , 1996.

, Cochrane Database of Systematic Reviews

A. Ulugol, The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation, Balk. Med. J, vol.31, pp.115-120, 2014.

S. N. Umathe, S. S. Manna, K. S. Utturwar, and N. S. Jain, Endocannabinoids mediate anxiolyticlike effect of acetaminophen via CB1 receptors, 2009.

, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.33, pp.1191-1199

S. Vandevoorde and C. J. Fowler, Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate, Br. J. Pharmacol, vol.145, pp.885-893, 2005.

H. Vanegas and H. Schaible, Descending control of persistent pain: inhibitory or facilitatory?, Brain Res. Rev, vol.46, pp.295-309, 2004.

H. Vanegas, E. Vazquez, and V. Tortorici, , 2010.

O. Nsaids, Cannabinoids and the Control of Pain by the Central Nervous System, Pharmaceuticals, vol.3, pp.1335-1347

J. R. Vane, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature. New Biol, vol.231, pp.232-235, 1971.

J. R. Vane and R. M. Botting, Mechanism of action of nonsteroidal anti-inflammatory drugs, Am. J. Med, vol.104, pp.2-8, 1998.

J. R. Vane, J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-bailey et al., Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. U. S. A, vol.91, p.2046, 1994.

D. M. Vialli and V. Erspamer, Cellule enterocromaffini e cellule basigranulose acidofile nei Vertebrati, Z. Für Zellforsch. Mikrosk. Anat, vol.19, pp.743-773, 1933.

M. B. Viana, F. G. Graeff, and P. Löschmann, Kainate Microinjection into the Dorsal Raphe Nucleus Induces 5-HT Release in the Amygdala and Periaqueductal Gray, Pharmacol. Biochem. Behav, vol.58, pp.167-172, 1997.

V. Mering, J. Walker, J. M. Huang, and S. M. , Beitrage zur Kenntniss der Antipyretica. Ther Monatsch 577-587, Pharmacol. Ther, vol.95, pp.127-135, 1893.

J. M. Walker, S. M. Huang, N. M. Strangman, K. Tsou, and M. C. Sañudo-peña, Pain modulation by release of the endogenous cannabinoid anandamide, Proc. Natl. Acad. Sci, vol.96, pp.12198-12203, 1999.

J. M. Walker, J. F. Krey, C. J. Chu, and S. M. Huang, Endocannabinoids and related fatty acid derivatives in pain modulation, Chem. Phys. Lipids, vol.121, pp.159-172, 2002.

J. M. Walker, N. M. Strangman, and S. M. Huang, Cannabinoids and pain, Pain Res. Manag. J. Can. Pain Soc. J. Société Can. Pour Trait. Douleur, vol.6, pp.74-79, 2001.

H. Wang and M. W. Wessendorf, Mu-and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla, Neuroscience, vol.109, pp.619-634, 2002.

S. M. Ward, J. Bayguinov, K. Won, D. Grundy, and H. R. Berthoud, Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract, J. Comp. Neurol, vol.465, pp.121-135, 2003.

T. D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell et al., Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis, Proc. Natl. Acad. Sci. U. S. A, vol.96, p.7563, 1999.

T. D. Warner, M. , and J. A. , Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.18, pp.790-804, 2004.

T. D. Warner, I. Vojnovic, F. Giuliano, R. Jiménez, D. Bishop-bailey et al., , 2004.

, Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat Tissues, J. Pharmacol. Exp. Ther, vol.310, pp.642-647

N. Watanabe, S. Horie, G. J. Michael, S. Keir, D. Spina et al., Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system, Neuroscience, vol.141, pp.1533-1543, 2006.

A. Wegman, D. Windt, . Van-der, M. Tulder, . Van et al., Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines, J. Rheumatol, vol.31, pp.344-354, 2004.

F. Wei, R. Dubner, S. Zou, K. Ren, G. Bai et al., Molecular Depletion of Descending Serotonin Unmasks Its Novel Facilitatory Role in the Development of Persistent Pain, J. Neurosci, vol.30, pp.8624-8636, 2010.

H. Wei, M. Saarnilehto, L. Falck, H. Viisanen, M. Lasierra et al., Spinal transient receptor potential ankyrin 1 channel induces mechanical hypersensitivity, increases cutaneous blood flow, and mediates the pronociceptive action of dynorphin A, J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc, vol.64, pp.331-340, 2013.

K. Weil, L. Hooper, Z. Afzal, M. Esposito, H. V. Worthington et al., , 2007.

, Paracetamol for pain relief after surgical removal of lower wisdom teeth, Cochrane Database Syst. Rev. CD004487

K. Westlund, L. Veraportocarrero, L. Zhang, J. Wei, M. Quast et al., fMRI of supraspinal areas after morphine and one week REFERENCES 233 pancreatic inflammation in rats, NeuroImage, vol.44, pp.23-34, 2009.

T. Wienecke and P. C. Gøtzsche, , 1996.

, Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis, Cochrane Database of Systematic Reviews

C. M. Williams, C. G. Maher, J. Latimer, A. J. Mclachlan, M. J. Hancock et al., Efficacy of paracetamol for acute low-back pain: a doubleblind, 2014.

F. G. Williams and A. J. Beitz, Ultrastructural morphometric analysis of GABA-immunoreactive terminals in the ventrocaudal periaqueductal grey: analysis of the relationship of GABA terminals and the GABAA receptor to periaqueductal grey-raphe magnus projection neurons, J. Neurocytol, vol.19, pp.686-696, 1990.

B. Wilsey, T. Marcotte, R. Deutsch, B. Gouaux, S. Sakai et al., Low-dose vaporized cannabis significantly improves neuropathic pain, J. Pain Off. J. Am. Pain Soc, vol.14, pp.136-148, 2013.

A. R. Wilson-poe, B. K. Lau, and C. W. Vaughan, Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey, Br. J. Pharmacol, 2014.

A. R. Wilson-poe, V. A. Mitchell, and C. W. Vaughan, Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey, Neuropharmacology, vol.66, pp.348-354, 2013.

A. R. Wilson-poe, M. M. Morgan, S. A. Aicher, and D. M. Hegarty, Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray, 2012.

C. W. Winkler, S. M. Hermes, C. I. Chavkin, C. T. Drake, S. F. Morrison et al., Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in OFF and NEUTRAL cells in the rostral ventromedial medulla, J. Neurophysiol, vol.96, pp.3465-3473, 2006.

J. Wiskerke, C. Irimia, B. F. Cravatt, T. J. Vries, . De et al., Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study, ACS Chem. Neurosci, vol.3, pp.138-147, 2012.

Y. Yiangou, P. Facer, N. Dyer, C. Chan, C. Knowles et al., Vanilloid receptor 1 immunoreactivity in inflamed human bowel, The Lancet, vol.357, pp.1338-1339, 2001.

Y. Yiangou, P. Facer, A. Ford, C. Brady, O. Wiseman et al., Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder: VR1 and P2X3 IN HUMAN URINARY BLADDER, BJU Int, vol.87, pp.774-779, 2002.

R. F. Young and V. I. Chambi, Pain relief by electrical stimulation of the periaqueductal and periventricular gray matter. Evidence for a nonopioid mechanism, J. Neurosurg, vol.66, pp.364-371, 1987.

L. Yu, F. Yang, H. Luo, F. Liu, J. Han et al., The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant, Mol. Pain, vol.4, p.61, 2008.

S. A. Zaitone, A. F. El-wakeil, A. , and S. H. , Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test, Behav. Pharmacol, vol.23, pp.417-425, 2012.

E. J. Zambraski, The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals, Semin. Nephrol, vol.15, pp.205-213, 1995.

K. P. Zeitz, N. Guy, A. B. Malmberg, S. Dirajlal, W. J. Martin et al., The 5-HT3 Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors, J. Neurosci, vol.22, pp.1010-1019, 2002.

W. Zhang, A. Jones, and M. Doherty, Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials, Ann. Rheum. Dis, vol.63, pp.901-907, 2004.

W. Zhang, Y. Liu, X. Zhao, X. Gu, M. et al., The effect of intrathecal administration TRPA1 antagonists in a rat model of neuropathic pain, Anesth. Analg, vol.119, pp.179-185, 2014.

Y. Zhang, Z. Yang, X. Gao, and G. Wu, The role of 5-hydroxytryptamine1A and 5hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenaninjected rats, Pain, vol.92, pp.201-211, 2001.

L. Zhao and G. Pickering, Paracetamol metabolism and related genetic differences, Drug Metab. Rev, vol.43, pp.41-52, 2011.

Z. Zhao, Neural mechanism underlying acupuncture analgesia, Prog. Neurobiol, vol.85, pp.355-375, 2008.

Z. Zhao, S. Chiechio, Y. Sun, K. Zhang, C. Zhao et al., Mice Lacking Central Serotonergic Neurons Show Enhanced Inflammatory Pain and an Impaired Analgesic Response to Antidepressant Drugs, J. Neurosci, vol.27, pp.6045-6053, 2007.

M. Zimmermann, Ethical guidelines for investigations of experimental pain in conscious animals, Pain, vol.16, pp.109-119, 1983.

P. M. Zygmunt, H. Chuang, P. Movahed, D. Julius, and E. D. Högestätt, The anandamide transport inhibitor AM404 activates vanilloid receptors, Eur. J. Pharmacol, vol.396, pp.39-42, 2000.

P. M. Zygmunt, A. Ermund, P. Movahed, D. A. Andersson, C. Simonsen et al., , 2013.

, Monoacylglycerols Activate TRPV1-A Link between Phospholipase C and TRPV1, PLoS ONE, vol.8, p.81618

P. M. Zygmunt, J. Petersson, D. A. Andersson, H. Chuang, M. Sørgård et al., Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, vol.400, pp.452-457, 1999.